REFERENCE: Abstract 1011 to 1016 Tony Gershlick, Leicester University A session entitled: “Stent Thrombosis in the Drug-Eluting Stents Era” at the Barcelona congress identified important m
REFERENCE: Abstract 1011 to 1016Tony Gershlick, Leicester University
A session entitled: “Stent Thrombosis in the Drug-Eluting Stents Era” at the Barcelona congress identified important mechanism, markers and strategies for avoiding stent thrombosis which can occur despite the use of drug-eluting stents, especially when dual anti-platelet therapy is discontinued.Tony Gershlickchaired the session, and afterwards discussed the findings with Peter Goodwin.
Related Episodes
TAXUS DES Trials Results: How Long Should Thienopyridine Be Used After Drug Eluting Stent?
Gregg Stone REFERENCE: Abstract 2357, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida GREGG STONE, Columbia University, New York New light has been thrown on the u
Long Term Outcomes of Drug Eluting and Bare Metal Stents in Patients Undergoing PCI
Laura Mauri Raymond Gibbons REFERENCE: Late Breaking Special Session, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida LAURA MAURI, Brigham and Woman’s Hospit
The Wingspan Stent: Safe Intra-Cranial Angioplasty?
FELIPE ALBUQUERQUE, Barrow Neurological Institute, Phoenix REFERENCE: Abstract 102 The Wingspan stent is a new approach to keeping open the atherosclerotic intracranial vessels of stroke and TIA patie